The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes with split-dose cisplatin-based regimens in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Results of a systematic literature review (SLR) and network meta-analysis (NMA).
 
Richard Thomas O'Dwyer
Research Funding - EMD Serono
 
Mairead Kearney
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck; Novartis; UCB
 
Mihaela Musat
Employment - Cytel
Consulting or Advisory Role - Merck KGaA
 
Ioana Gulas
Employment - Cytel
 
Silke Guenther
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
Elizabeth Hubscher
Employment - Cytel
Consulting or Advisory Role - Merck KGaA
 
Hoora Moradian
Employment - Cytel
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)